An interventional study of Duloxetine in Acute Pain, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-06-24.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
The objective of this study is to evaluate the analgesic effect of oral dulexitine tablet (administered 2 h before surgery) as well as the ideal dose for acute postmastectomy pain.
patients undergoing mastectomy with axillary evacuation will be divided to four groups, Placebo group: received placebo capsule Duloxetine 30: received duloxetine 30 mg capsule Duloxetine 60: received duloxetine 60 mg capsule Duloxetine 90: received duloxetine 90 mg capsule the study medication is administered orall 2 h before surgery. Primary outcome variable: the first postoperative 24 h morphine consumption Secondary outcome: the VAS pain score measured every 4 h in the first 24 h postoperatively.
Exclusion Criteria:
Drug: Duloxetine
Drug: Duloxetine
Drug: Duloxetine
Drug: Duloxetine
patients scheduled for mastectomy and axillary evacuation for cancer breast will receive orally, 2 hours before the operation either, placebo capsule, duloxetine 30 mg,duloxetine 60 mg or duloxetine 90 mg capsule.
the first postoperative 24 h (patient controlled analgesia [PCA])morphine consumption
the cumulative patient controlled analgesia morphine consumption required by the patients to relieve their pain in the first postoperative 24 h
Time frame: the first postoperative 24 hour
The intensity of pain measured by visual analogue pain scale (VAS)
The intensity of pain measured by visual analogue pain scale (VAS) in which 0 = no pain and 10 = the maximum imaginable pain
Time frame: The outcome will be assessed at 0 hour, 2 hour, 4 hour,8 hour, 16 hour and 24 hour postoperatively.
The quality of postoperative recovery, assessed by "The QoR-40 questionnaire" (the quality of recovery-40 questionnaire)
It measures five components of patient recovery: physical comfort (12 questions), physical independence (5 questions), emotional state (9 questions), psychological support (7 questions), and pain (7 questions). The sum of each component generates an aggregate score that ranges from 40 (i.e., extremely poor quality of recovery) to 200 (i.e., excellent quality of recovery)
Time frame: the questionnair will be assessed once, 24 hour postoperatively
The level of consciousness assessed by "the Modified Ramsay Sedation score"
awake levels were: I = anxious, agitated, or restless; II = cooperative, oriented, and tranquil; III = responds to command, and asleep levels were dependent on patient's response to a light glabellar tap or loud auditory stimulus; IV= brisk response; V = a sluggish response; and VI = no response)
Time frame: the score will be measured at 8 hour, 16 hour and 24 hour postoperatively
The occurrence of vomiting
vomiting is forceful discharge of stomach contents
Time frame: The outcome will be obtained once 24 hour postoperatively
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University